[HTML][HTML] Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals
…, E Eliassian, O Shimron, L Saleh, H Ben-Zvi… - Nature medicine, 2021 - nature.com
The BNT162b2 mRNA vaccine is highly effective against SARS-CoV-2. However, apprehension
exists that variants of concern (VOCs) may evade vaccine protection, due to evidence of …
exists that variants of concern (VOCs) may evade vaccine protection, due to evidence of …
Evaluation of seropositivity following BNT162b2 messenger RNA vaccination for SARS-CoV-2 in patients undergoing treatment for cancer
…, A Zer, A Benouaich-Amiel, H Ben-Zvi… - JAMA …, 2021 - jamanetwork.com
Importance Patients with cancer undergoing treatment are at high risk of COVID-19 following
SARS-CoV-2 infection; however, their ability to produce an adequate antibody response to …
SARS-CoV-2 infection; however, their ability to produce an adequate antibody response to …
[HTML][HTML] Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients
N Shafran, I Shafran, H Ben-Zvi, S Sofer, L Sheena… - Scientific reports, 2021 - nature.com
Secondary bacterial infections are a potentially fatal complication of influenza infection. We
aimed to define the impact of secondary bacterial infections on the clinical course and …
aimed to define the impact of secondary bacterial infections on the clinical course and …
[HTML][HTML] Antibody response to SARS-CoV-2 mRNA vaccine among kidney transplant recipients: a prospective cohort study
…, D Yahav, T Agur, B Zingerman, H Ben-Zvi… - Clinical Microbiology …, 2021 - Elsevier
Objectives We aimed to evaluate the rates of antibody response to severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine among kidney transplant recipients, …
syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine among kidney transplant recipients, …
[HTML][HTML] Nationwide outbreak of Candida auris infections driven by COVID-19 hospitalizations, Israel, 2021–2022
We report an outbreak of Candida auris across multiple healthcare facilities in Israel. For the
period of May 2014–May 2022, a total of 209 patients with C. auris infection or colonization …
period of May 2014–May 2022, a total of 209 patients with C. auris infection or colonization …
Lower serologic response to COVID-19 mRNA vaccine in patients with inflammatory bowel diseases treated with anti-TNFα
H Edelman-Klapper, E Zittan, ABG Shitrit… - Gastroenterology, 2022 - Elsevier
Background & Aim Patients with inflammatory bowel diseases (IBD), specifically those
treated with anti–tumor necrosis factor (TNF)α biologics, are at high risk for vaccine-preventable …
treated with anti–tumor necrosis factor (TNF)α biologics, are at high risk for vaccine-preventable …
Immunogenicity of the BNT162b2 mRNA vaccine in heart transplant recipients–a prospective cohort study
…, B Ben‐Avraham, V Yaari, H Ben Zvi… - European Journal of …, 2021 - Wiley Online Library
Aims To assess the short‐term immunogenicity to severe acute respiratory syndrome coronavirus
2 (SARS‐CoV‐2) mRNA vaccine in a population of heart transplant (HTx) recipients. A …
2 (SARS‐CoV‐2) mRNA vaccine in a population of heart transplant (HTx) recipients. A …
[HTML][HTML] Early humoral response among lung transplant recipients vaccinated with BNT162b2 vaccine
Y Shostak, N Shafran, M Heching… - The Lancet …, 2021 - thelancet.com
Lung transplant recipients are given immunosuppressive therapy that might impair their
ability to generate an adequate immune response to the BNT162b2 vaccine. 1 However, …
ability to generate an adequate immune response to the BNT162b2 vaccine. 1 However, …
[HTML][HTML] Humoral serological response to the BNT162b2 vaccine is abrogated in lymphoma patients within the first 12 months following treatment with anti-CD2O …
…, C Leibovitch, P Raanani, H Ben-Zvi… - …, 2022 - ncbi.nlm.nih.gov
Patients with lymphoma, especially those treated with anti-CD20 monoclonal antibodies,
suffer high COVID-19-associated morbidity and mortality. The goal of this study was to assess …
suffer high COVID-19-associated morbidity and mortality. The goal of this study was to assess …
[HTML][HTML] A real-life setting evaluation of the effect of remdesivir on viral load in COVID-19 patients admitted to a large tertiary centre in Israel
E Goldberg, HB Zvi, L Sheena, S Sofer, I Krause… - Clinical Microbiology …, 2021 - Elsevier
Objectives The effectiveness of remdesivir, a Food and Drug Administration-approved drug
for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been repeatedly …
for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has been repeatedly …